{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:33:15Z","timestamp":1791923595969,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.msard.2018.07.011","type":"journal-article","created":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T22:30:57Z","timestamp":1531175457000},"page":"21-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Cardiovascular conditions in persons with multiple sclerosis, neuromyelitis optica and transverse myelitis"],"prefix":"10.1016","volume":"25","author":[{"given":"Paola","family":"Saroufim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia A.","family":"Zweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devon S.","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0903-1359","authenticated-orcid":false,"given":"Farren B.S.","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2018.07.011_bib0001","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jns.2017.11.022","article-title":"Evaluation of comorbidities and health care resource use among patients with highly active neuromyelitis optica","volume":"384","author":"Ajmera","year":"2018","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.msard.2018.07.011_bib0002","first-page":"180","article-title":"Follow-up of hypertension in patients with multiple sclerosis","volume":"15","author":"Baghbanian","year":"2016","journal-title":"Iran J. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2018.07.011_bib0003","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/EDE.0000000000000089","article-title":"Smoking and risk of multiple sclerosis: evidence of modification by NAT1 variants","volume":"25","author":"Briggs","year":"2014","journal-title":"Epidemiol."},{"issue":"7","key":"10.1016\/j.msard.2018.07.011_bib0004","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/jech-2013-203184","article-title":"Adverse socioeconomic position during the life course is associated with multiple sclerosis","volume":"68","author":"Briggs","year":"2014","journal-title":"J. Epidemiol. Commun. Health"},{"issue":"6","key":"10.1016\/j.msard.2018.07.011_bib0005","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.msard.2015.08.005","article-title":"Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: an observational study using the US department of defense administrative claims database","volume":"4","author":"Capkun","year":"2015","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2018.07.011_bib0006","article-title":"Influence of hypertension, diabetes, hyperlipidemia, and obstructive lung disease on multiple sclerosis disease course","author":"Conway","year":"2016","journal-title":"Multi. Sclero."},{"issue":"1","key":"10.1016\/j.msard.2018.07.011_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7224\/1537-2073.2016-021","article-title":"Sedentary behavior and blood pressure in patients with multiple sclerosis","volume":"20","author":"Hubbard","year":"2018","journal-title":"Int. J. M.S. Care"},{"issue":"9","key":"10.1016\/j.msard.2018.07.011_bib0008","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1007\/s00415-015-7796-2","article-title":"Epidemiology of multiple sclerosis: results from a large observational study in the UK","volume":"262","author":"Jick","year":"2015","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2018.07.011_bib0009","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/jnnp-2014-308984","article-title":"Overlapping CNS inflammatory diseases: differentiating features of NMO and MS","volume":"86","author":"Jurynczyk","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.msard.2018.07.011_bib0010","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nrneurol.2017.33","article-title":"Comorbidity in multiple sclerosis: implications for patient care","volume":"13","author":"Marrie","year":"2017","journal-title":"Nature Rev. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2018.07.011_bib0011","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1352458514564491","article-title":"A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview","volume":"21","author":"Marrie","year":"2015","journal-title":"Multi. Sclero."},{"issue":"3","key":"10.1016\/j.msard.2018.07.011_bib0012","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1600-0404.2011.01526.x","article-title":"Cumulative impact of comorbidity on quality of life in MS","volume":"125","author":"Marrie","year":"2012","journal-title":"Acta. Neurol. Scand."},{"issue":"2","key":"10.1016\/j.msard.2018.07.011_bib0013","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1212\/01.wnl.0000333252.78173.5f","article-title":"Comorbidity delays diagnosis and increases disability at diagnosis in MS","volume":"72","author":"Marrie","year":"2009","journal-title":"Neurol."},{"issue":"13","key":"10.1016\/j.msard.2018.07.011_bib0014","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/WNL.0b013e3181d6b125","article-title":"Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis","volume":"74","author":"Marrie","year":"2010","journal-title":"Neurol."},{"issue":"9","key":"10.1016\/j.msard.2018.07.011_bib0015","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1177\/1352458512437814","article-title":"Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia","volume":"18","author":"Marrie","year":"2012","journal-title":"Multi. Sclero."},{"key":"10.1016\/j.msard.2018.07.011_bib0016","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neuro.2016.03.020","article-title":"Factors associated with onset, relapses or progression in multiple sclerosis: a systematic review","volume":"61","author":"McKay","year":"2017","journal-title":"Neurotoxicol."},{"issue":"9","key":"10.1016\/j.msard.2018.07.011_bib0017","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1007\/s00415-013-6977-0","article-title":"Cerebrovascular hemodynamic changes in multiple sclerosis patients during head-up tilt table test: effect of high-dose intravenous steroid treatment","volume":"260","author":"Mezei","year":"2013","journal-title":"J. Neurol."},{"issue":"8","key":"10.1016\/j.msard.2018.07.011_bib0018","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/ene.12720","article-title":"The Framingham cardiovascular risk score in multiple sclerosis","volume":"22","author":"Moccia","year":"2015","journal-title":"Eur. J. Neurol."},{"issue":"7","key":"10.1016\/j.msard.2018.07.011_bib0019","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/jcbfm.2011.197","article-title":"Neurological diseases in relation to the blood-brain barrier","volume":"32","author":"Rosenberg","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"3","key":"10.1016\/j.msard.2018.07.011_bib0020","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1113\/EP086434","article-title":"The role of the blood-brain barrier in hypertension","volume":"103","author":"Setiadi","year":"2018","journal-title":"Exp. Physiol."},{"issue":"6","key":"10.1016\/j.msard.2018.07.011_bib0021","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1177\/1352458514551780","article-title":"Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis","volume":"21","author":"Simon","year":"2015","journal-title":"Multi. Sclero."},{"issue":"1","key":"10.1016\/j.msard.2018.07.011_bib0022","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s12035-015-9599-y","article-title":"Impaired neurovisceral integration of cardiovascular modulation contributes to multiple sclerosis morbidities","volume":"54","author":"Sternberg","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.msard.2018.07.011_bib0023","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2174\/1871527311312010016","article-title":"The prevalence of the classical and non-classical cardiovascular risk factors in multiple sclerosis patients","volume":"12","author":"Sternberg","year":"2013","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"2","key":"10.1016\/j.msard.2018.07.011_bib0024","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/1755-5922.12049","article-title":"Disease modifying therapies modulate cardiovascular risk factors in patients with multiple sclerosis","volume":"32","author":"Sternberg","year":"2014","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.msard.2018.07.011_bib0025","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-016-8295-9","article-title":"Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark","author":"Thormann","year":"2016","journal-title":"J. Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034818302207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034818302207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:45:21Z","timestamp":1761900321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034818302207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":25,"alternative-id":["S2211034818302207"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2018.07.011","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular conditions in persons with multiple sclerosis, neuromyelitis optica and transverse myelitis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2018.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}